Investigational Site Number 158001

Taipei 112

0 studies enrolling now · 9 studies all time

What they study most

Acute Coronary Syndrome, Asthma, Atherosclerotic Cardiovascular Disease, Hematopoietic Neoplasm, Pompe Disease, Prostate Cancer, Rheumatoid Arthritis

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• Alglucosidase Alfa Pompe Safety Sub-Registry — Completed
• Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer — Completed
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) — Completed
• Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients — Completed
• Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer — Completed
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) — Completed
• Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy — Completed